Bulk Drug Intermediates
Auschemicals provide varies kinds of Bulk Drug Intermediates .
Bulk Drug Intermediates
| STRUCTURE | CHEMICAL NAME | CAS | MF | |
|---|---|---|---|---|
| (3S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid | 291775-59-2 | C12H19NO4 | ||
| (1S,2S,3R,5S)-(+)-2,3-Pinanediol | 18680-27-8 | C10H18O2 | ||
| Ruxolitinib | 941678-49-5 | C17H18N6 | ||
| 2,3-Dihydrobenzofuranyl-5-acetic acid | 69999-16-2 | C10H10O3 | ||
| Potassium di-tert-butyl phosphate | 33494-80-3 | C8H20KO4P | ||
| 6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride | 84163-13-3 | C12H14ClFN2O | ||
| 1-AMINOINDANE HYDROCHLORIDE | 70146-15-5 | C9H12ClN | ||
| 7-Fluoro-6-nitro-4-hydroxyquinazoline | 162012-69-3 | C8H4FN3O3 | ||
| (S)-1-(2,6-Dichloro-3-fluorophenyl)ethanol | 877397-65-4 | C8H7Cl2FO | ||
| 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | 253870-02-9 | C8H9NO3 | ||
| Ibrutinib | 936563-96-1 | C25H24N6O2 | ||
| (S)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 | C4H8O2 | ||
| 3-(4-Chlorbutyl)-1H-indol-5-carbonitril | 143612-79-7 | C13H13ClN2 | ||
| 4-N-Boc-aminocyclohexanone | 179321-49-4 | C11H19NO3 | ||
| 6-IODO (1H)INDAZOLE | 261953-36-0 | C7H5IN2 | ||
| (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester | 149809-43-8 | C21H21F2N3O4S | ||
| (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester | 361440-67-7 | C11H18N2O3 | ||
| 1-(5-Bromo-2-methoxy-phenyl)adamantane | 104224-63-7 | C17H21BrO | ||
| (R)-N-Boc-2-Hydroxymethylmorpholine | 135065-71-3 | C10H19NO4 | ||
| (R)-1-Boc-3-Hydroxypiperidine | 143900-43-0 | C10H19NO3 | ||
| [3-(Dimethylamino)propyl]triphenylphosphonium bromide hydrobromide | 27710-82-3 | C23H28Br2NP | ||
| 1-Chloro-6,6-dimethyl-2-heptene-4-yne | 83554-69-2 | C10H17N | ||
| ((2R,3R,4R)-3-(benzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate | 874638-80-9 | C20H17FO6 | ||
| (3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one | 32384-65-9 | C18H42O6Si4 | ||
| ISOPROPYLHYDRAZINE HYDROCHLORIDE | 16726-41-3 | C3H11ClN2 | ||
| 5-Fluoro-2-oxindole | 56341-41-4 | C8H6FNO | ||
| 4-(4-AMINOPHENYL)MORPHOLIN-3-ONE | 438056-69-0 | C10H12N2O2 | ||
| Methyl 4-amino-5-ethylsulfonyl-2-methoxybenzoate | 80036-89-1 | C11H15NO5S | ||
| 4-Amino-2-methyl-10H-thiene[2,3-b][1,5]benzodiazepine hydrochloride | 138564-60-0 | C12H12ClN3S | ||
| (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 207557-35-5 | C7H9ClN2O | ||
| 3-Carbamoymethyl-5-methylhexanoic acid | 181289-15-6 | C9H17NO3 | ||
| (S)-N-Boc-2-Hydroxymethylmorpholine | 135065-76-8 | C10H19NO4 | ||
| 8-Bromo-3-methyl-xanthine | 93703-24-3 | C6H5BrN4O2 | ||
| Guaiacol glycidyl ether | 2210-74-4 | C10H12O3 | ||
| 4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro- | 162012-67-1 | C14H7ClF2N4O2 | ||
| 2-Chloro-1-(3,4-difluoro-phenyl)-ethanone | 51336-95-9 | C8H5ClF2O | ||
| 4-Cloromethyl-5-methyl-1,3-dioxol-2-one | 80841-78-7 | C5H5ClO3 | ||
| 3-Aminophenylacetylene | 54060-30-9 | C8H7N | ||
| cis-Octahydroisoindole | 1470-99-1 | C8H15N | ||
| 5-(2-Bromoethyl)-2,3-dihydrobenzofuran | 127264-14-6 | C10H11BrO | ||
| Valdecoxib | 181695-72-7 | C16H14N2O3S | ||
| 4-Amino-5-ethylsulfonyl-2-methoxybenzoic acid | 71675-87-1 | C10H13NO5S | ||
| ((5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate | 144163-97-3 | C11H8N2O5S | ||
| (R)-1-(2,6-Dichloro-3-fluorophenyl)ethanol | 330156-50-8 | C8H7Cl2FO | ||
| 4'-TRIFLUOROMETHYL-BIPHENYL-4-CARBALDEHYDE | 90035-34-0 | C14H9F3O | ||
| 6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone | 179688-29-0 | C14H18N2O5 | ||
| DDQ | 84-58-2 | C8Cl2N2O2 | ||
| Alogliptin benzoate | 850649-62-6 | C25H27N5O4 | ||
| (R)-(-)-3-Pyrrolidinol hydrochloride | 104706-47-0 | C4H10ClNO | ||
| 3-Chloro-4-(3-fluorobenzyloxy)aniline | 202197-26-0 | C13H11ClFNO | ||
| 2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene | 898566-17-1 | C18H14FIS | ||
| (R)-3-(Boc-Amino)piperidine | 309956-78-3 | C10H20N2O2 | ||
| (S)-1-Boc-3-hydroxypiperidine | 143900-44-1 | C10H19NO3 | ||
| 2'-deoxy-2'-fluoro-2'-C-methyluridine | 863329-66-2 | C10H13FN2O5 | ||
| N-(2-chloropyriMidin-4-yl)-N,2,3-triMethyl-2H-indazol-6-aMine | 444731-75-3 | C14H14ClN5 | ||
| 10-Nitrocamptothecin | 86639-62-5 | C20H15N3O6 | ||
| Benzene, 4-[(2R)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)- | 324763-39-5 | C17H27ClO3 | ||
| methyl 3-amino-2-fluorobenzoate | 1195768-18-3 | C8H8FNO2 | ||
| ledipasvir interMediate | 1256387-87-7 | C24H34BN3O4 | ||
| VX-770 | 873054-44-5 | C24H28N2O3 | ||
| 1-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-2-chloro-Ethanone | 1378387-81-5 | C15H8BrClF2O | ||
| 2,3-DIMETHYL-2H-INDAZOL-6-AMINE | 444731-72-0 | C9H11N3 | ||
| 2,3-dimethyl-2H-indazol-6-amine hydrochloride | 635702-60-2 | C9H12ClN3 | ||
| (S)-5-BOC-5-AZASPIRO[2.4]HEPTANE-6-CARBOXYLIC ACID | 1129634-44-1 | C12H19NO4 | ||
| 2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-(6-broMo-1H-benziMidazol-2-yl)-, 1,1-diMethylethyl ester,(1R,3S,4S)- | 1256387-74-2 | C18H22BrN3O2 | ||
| 5-Methyl-3,4-diphenylisoxazole | 37928-17-9 | C16H13NO | ||
| PSI-6130 derivative | 817204-32-3 | C31H26FN3O7 | ||
| (R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine | 877399-00-3 | C13H10BrCl2FN2O | ||
| (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate | 376608-71-8 | C17H17F2NO3 | ||
| ledipasvir interMediate | 1441670-89-8 | C27H26BrF2N3O2 | ||
| (R)-3-Piperidinamine dihydrochloride | 334618-23-4 | C5H14Cl2N2 | ||
| 3-(1-Piperidinylmethyl)phenol | 73279-04-6 | C12H17NO | ||
| 3''-AMINO-2''-HYDROXY-BIPHENYL-3-CARBOXYLIC ACID | 376592-93-7 | C13H11NO3 | ||
| tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate | 877399-74-1 | C19H32BN3O4 | ||
| Linagliptin | 668270-12-0 | C25H28N8O2 | ||
| 6-AMIDINO-2-NAPHTHOL METHANESULFONATE | 82957-06-0 | C12H14N2O4S | ||
| 2-(chloromethyl)-4-methylquinazoline | 109113-72-6 | C10H9ClN2 | ||
| 4-Bromo-1-methoxy-2-(3-methoxy-propoxy)-benzene | 173336-76-0 | C11H15BrO3 | ||
| (S)-(+)-GLYCIDYL PHTHALIMIDE | 161596-47-0 | C11H9NO3 | ||
| 1-Methyl-aminomethyl naphthalene | 14489-75-9 | C12H13N | ||
| 4-Isopropoxyethoxymethylphenol | 177034-57-0 | C12H18O3 | ||
| 5-Hydroxymethylthiazole | 38585-74-9 | C4H5NOS | ||
| macitentan | 441798-33-0 | C19H20Br2N6O4S | ||
| 2,3-DIMETHYL-6-NITRO-2H-INDAZOLE | 444731-73-1 | C9H9N3O2 | ||
| (1R,2R)-1,2-CYCLOHEXANEDIMETHANOL | 65376-05-8 | C8H16O2 | ||
| N-methyl-2-sulfanylbenzamide | 20054-45-9 | C8H9NOS | ||
| Unii-4U07F515lg | 496775-62-3 | C27H29N5O5 | ||
| Ruxolitinib phosphate | 1092939-17-7 | C17H21N6O4P | ||
| N-(tert-Butoxycarbonyl)-4-piperidone | 79099-07-3 | C10H17NO3 | ||
| 2-CYANO-5-FLUOROBENZYL BROMIDE | 421552-12-7 | C8H5BrFN | ||
| trans-4-Dimethylaminocrotonic acid hydrochloride | 848133-35-7 | C6H12ClNO2 | ||
| Pimavanserin | 706779-91-1 | C25H34FN3O2 | ||
| Dapagliflozin | 461432-26-8 | C21H25ClO6 | ||
| (S)-3-(1-Cyano-1,1-diphenylmethyl)-1-tosylpyrrolidine | 133099-09-9 | C25H24N2O2S | ||
| 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | 641571-11-1 | C11H10F3N3 | ||
| 6-Iodoquinazolin-4-one | 16064-08-7 | C8H5IN2O | ||
| Tofacitinib citrate | 540737-29-9 | C16H20N6O.C6H8O7 | ||
| 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid | 376608-65-0 | C14H25NO10 | ||
| (S)-2-Benzylsuccinic acid | 3972-36-9 | C11H12O4 | ||
| 2-(1-Adamantyl)-4-bromophenol | 104224-68-2 | C16H19BrO | ||
| N-(2-chloropyriMidin-4-yl)-2,3-diMethyl-2H- indazol-6-aMine | 444731-74-2 | C13H12ClN5 | ||
| 6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one | 1016636-76-2 | C13H13BrClN3O | ||
| Trelagliptin succinate | 1029877-94-8 | C22H26FN5O6 | ||
| TAK-438 | 1260141-27-2 | C21H20FN3O6S | ||
| 5-Chloro-3-[N-(methoxy-carbonyl-methyl)sulfamoyl]-2-thiophene carboxylic acid methyl ester | 70374-38-8 | C10H12ClNO6S2 | ||
| (6R,S)-5,6,7,8-TETRAHYDRO-L-BIOPTERIN DIHYDROCHLORIDE | 62989-33-7 | C9H15N5O3 | ||
| 2,2',7,7'-Tetrakis[N,N-di(4-methoxyphenyl)amino]-9,9'-spirobifluorene | 207739-72-8 | C81H68N4O8 | ||
| ledipasvir interMediate | 1441673-92-2 | C12H19NO4 | ||
| 1-(3,4-DIMETHYLPHENYL)-3-METHYL-3-PYRAZOLIN-5-ONE | 18048-64-1 | C12H14N2O | ||
| 4-Benzofurancarboxylic Acid | 166599-84-4 | C9H6O3 | ||
| Methyl 5-chloro-3-chlorosulfonyl-2-thiophene carboxylate | 70374-37-7 | C7H8ClNO4S2 | ||
| 2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid | 70785-61-4 | C15H14N2O5 | ||
| 2-(3,4-Dimethylphenyl)-1,2-dihydro-5-methyl-3H-pyrazol-3-one | 277299-70-4 | C12H14N2O | ||
| 3-(S)-(1-Carbamoyl-1,1-diphenylmethyl)pyrrolidine | 134002-25-8 | C18H20N2O | ||
| (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine | 477600-70-7 | C14H22N2 | ||
| 2'-Bromo-2'-deoxyuridine | 72218-68-9 | C9H11BrN2O5 | ||
| Itraconzole intermediate | ||||
| (2R,3R,4R,5R)-4-(Acetyloxy)-2-(5-fluoro-4-formamido-2-oxo-1,2-dihydropyrimidin-1-yl)-5-methyloxolan-3-yl acetate | ||||
| 1(2H)-Pyridinecarboxylic acid, 2-(aminocarbonyl)-3,6-dihydro-3-methyl-, 1,1-dimethylethyl ester, (2S,3R)- | 2209874-09-7 | C12H20N2O3 | ||
| 6-METHYLENEANDROST-4-ENE-3,17-DIONE | 19457-55-7 | C20H26O2 | ||
| 5'-Methoxylaudanosine | 24734-71-2 | C22H29NO5 | ||
| Perfluoro(4-methyl-3,6-dioxaoct-7-ene)sulfonyl fluoride | 16090-14-5 | C7F14O4S | ||
| 7-METHOXY-4-(TRIFLUOROMETHYL)COUMARIN | 575-04-2 | C11H7F3O3 | ||
| 4-[3-(Trifluoromethyl)phenyl]-1-piperazineethanol | 40004-29-3 | C13H17F3N2O | ||
| 1H-ISOINDOLE-1,3(2H)-DIONE, 2-[[(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-5-OXAZOLIDINYL]METHYL]- | 446292-08-6 | C22H19N3O6 | ||
| 3-Iodo-1H-pyrazole | 4522-35-4 | C3H3IN2 | ||
| 1-Azepanyl(4,5,6,7-tetrahydro-1H-pyrazolo-[4,3-c]pyridin-3-yl)methanone hydrochloride | 1219982-46-3 | C13H21ClN4O | ||
| Methyl 5-chloro-6-methylpyrazine-2-carboxylate | 77168-85-5 | C7H7ClN2O2 | ||
| Orlistat pellets | ||||
| N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester | 1334513-02-8 | C18H17F5NO5P | ||
| 5,6,12,13-tetrabromo-Perylo[3,4-cd:9,10-c'd']dipyran-1,3,8,10-tetrone | 321945-85-1 | C24H4Br4O6 | ||
| Ofloxacin EP Impurity C | 95848-94-5 | C18H21N3O4 | ||
| Posaconazole Diastereoisomer 11 | 171228-50-5 | C37H42F2N8O4 | ||
| 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | 941688-05-7 | C17H18N6 | ||
| Eribulin intermediate | 157322-47-9 | C21H35IO4 | ||
| Azacitidine Impurity 3 | 157771-77-2 | C8H12N4O5 | ||
| Lumacaftor Intermediate | 936727-68-3 | C17H13ClF2N2O3 | ||
| (4-bromo-2-fluorophenyl)-(3,4,5-trimethoxyphenyl)methanone | 1016544-26-5 | C16H14BrFO4 | ||
| 6R,7S-Ceftazidime isomer | ||||
| Oseltamivir Fructose Adduct 2 | ||||
| Sugammadex sodium Pentabromide intermediate | ||||
| (3S,5S,2S,3R)-posaconazole | ||||
| tert-butyl N-[(1R,3R,4R)-3-hydroxy-4-sulfanylcyclohexyl]carbamate | 1350636-75-7 | C11H21NO3S | ||
| Isopropyl creatinine | C7H13N3O | |||
| 2-(4-NITROPHENYL)BUTYRIC ACID | 7463-53-8 | C10H11NO4 | ||
| Ceftiofur Double Side Chain | ||||
| Flomoxef Intermediate F3-01 | ||||
| 5-Pyrimidineacetamide, 2-butyl-1-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-1,6-dihydro-N,N,4-trimethyl-6-oxo- | 1985668-78-7 | C27H30N4O2 | ||
| 2',3'-Dideoxy-2',3'-didehydroinosine | 42867-68-5 | C10H10N4O3 | ||
| Cephalosporin | 11111-12-9 | C16H21N3O8S | ||
| 3-[2-(3,4-dimethoxybenzoyl)-4,5-dimethoxyphenyl]pentan-2-one | 15462-91-6 | C22H26O6 | ||
| potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate | 5991-71-9 | C16H10ClKN2O3 | ||
| hexahydro-1-methyl-3-(3-oxo-1-cyclohexen-1-yl)-2H-azepin-2-one | 71556-70-2 | C13H19NO2 | ||
| alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylphenethyl alcohol | 73404-00-9 | C26H31NO2 | ||
| methyl ibogamine-18-carboxylate | 467-77-6 | C21H26N2O2 | ||
| 4-Methylcumarin | 607-71-6 | C10H8O2 | ||
| NA | ||||
| BORTEZOMIB-PINANEDIOL | 205393-22-2 | C29H39BN4O4 | ||
| 4-AMINO-CHROMEN-2-ONE | 53348-92-8 | C9H7NO2 | ||
| [402960-19-4],C9H18N2O2, 186.40 | 850252-34-5 | C9H19ClN2O2 | ||
| a-D-Glucopyranoside,methyl 4-O-[2-O-acetyl-6-methyl-3-O-(phenylmethyl)-a-L-idopyranuronosyl]-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-,6-acetate | 114869-97-5 | C40H47NO15 | ||
| 8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone | 530084-79-8 | C18H16BrNO3 | ||
| RebaMipide interMediate product | 169809-59-0 | C19H16ClN2NaO4 | ||
| (7alpha,17beta)-17-(Acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estr-4-en-3-one | 415927-29-6 | C34H51F5O3S | ||
| 5-Bromo-2-methylbenzoic acid | 79669-49-1 | C8H7BrO2 | ||
| EthanediaMide iMpurity F hcl | 482375-18-8 | C2H4N2O2 | ||
| N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine | 1702274-61-0 | C20H25N5 | ||
| Coumarin | 15938-72-4 | C28H22O9 | ||
| Engelide intermediate | ||||
| Ethyl 4-acetoxy-6,7-difluoro-2-(ethylthio)quinoline-3-carboxylate | 154330-68-4 | C16H15F2NO4S | ||
| Cefiderocol | 1225208-94-5 | C30H34ClN7O10S2 | ||
| 2,3-Dimethylbenzyl alcohol | 13651-14-4 | C9H12O | ||
| (1R)-(+)-TRANS-PINANE | 4863-59-6 | C10H18 | ||
| 5-Methyl-4-isoxazolecarboxylic acid | 42831-50-5 | C5H5NO3 | ||
| Material intermediate | 162039-67-0 | C18H14N4 | ||
| (3-BROMOACETYL)COUMARIN | 29310-88-1 | C11H7BrO3 | ||
| Sugammadex sodium Heptabromide intermediate | ||||
| Cefotiam (6R,7S) isomer reference | ||||
| Ceftiofur Double Mother Nucleus | ||||
| 7S-Cephalexin | ||||
| (6R,7S)-Latamoxef MotherNucleus | ||||
| COUMARIN 6 | 88241-65-0 | C15H12O2 | ||
| FLUTICASONE PROPIONATE INTERMEDIATE | 80474-45-9 | C24H30F2O5S | ||
| 2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol | 142569-70-8 | C29H28ClNO2 | ||
| cytidylyl-(5'->3')-guanosine | 4785-04-0 | C19H25N8O12P | ||
| (6R-trans)-3-(acetoxymethyl)-7-[(2-aminothiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 58233-18-4 | C15H16N4O6S2 | ||
| 4-(dimethylammonio)piperidinium dichloride | 4876-59-9 | C7H18Cl2N2 | ||
| NA | ||||
| (7S)-Cefuroxime | ||||
| 5-phenyl-2,3,7-tris(phenylamino)phenazinium chloride | 4935-81-3 | C36H28ClN5 | ||
| 6,7-DIHYDROXY-4-(TRIFLUOROMETHYL)COUMARIN | 82747-36-2 | C10H5F3O4 | ||
| 455284-06-7 | 455284-06-7 | |||
| N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide | 122584-18-3 | C17H18BrNO4 | ||
| 2'-iodo-2'-deoxyuridine | 1042098 | C9H11IN2O5 | ||
| (1S,2R,3S,5R)-3-(Phenymethyloxy)-2-(phenylmethoxy)methyl-6-oxabicyclo[3.1.0]hexane | 110567-22-1 | C20H22O3 | ||
| (4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine | 209401-69-4 | C6H12N2O | ||
| 1-Acetyl-4-(4-hydroxyphenyl)piperazine side chain of Ketoconazole | 67914-99-2 | C13H18N2O3 | ||
| (R)-Levofloxacin | C18H20FN3O4 | |||
| Piperazine, 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)- (acetate) | 906093-30-9 | C16H22N4O2 | ||
| 3,3-Ethylenedioxy-17β-cyano-17α-trimethylsilyloxyestra-5(10)9(11)-diene | 54690-63-0 | C24H35NO3Si | ||
| NA | ||||
| INTERMEDIATES | 1243021-74-0 | C13H26N2O5 | ||
| ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydroquinoline-4-oxo-3-carboxyla | 99696-21-6 | C15H12ClF2NO3 | ||
| 2'-DEOXYCYTIDINE MONOHYDRATE, 99+% | 652157-52-3 | C9H15N3O5 | ||
| tert-butyl (3R,6S)-3-((tert-butoxycarbonyl)((tert-butyldimethylsilyl)oxy)amino) -6-carbamoyl -5-methyl-3,6-dihydropyridine-1(2H)-carboxylate | 2209874-00-8 | C23H43N3O6Si | ||
| (3R,3αS,6αR)-Hydroxyhexa-hydrofuro[2,3-β]furan-3-yl acetate | 186488-43-7 | C8H12O5 | ||
| 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione | 853029-57-9 | C20H17BrN6O2 | ||
| 4-[[6-[(1-Oxo-2-propen-1-yl)oxy]hexyl]oxy]benzoic acid 1,1'-(1,4-phenylene) ester | 123864-17-5 | C38H42O10 | ||
| (S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine | 314771-76-1 | C18H16ClFN4O2 | ||
| RTI 4229-111 | 150653-91-1 | C16H20Cl3NO2 | ||
| (3S,4R,5R)-Oseltamivir | ||||
| 2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid | ||||
| 7-amino-3-phenyl-2-benzopyrone | 4108-61-6 | C15H11NO2 | ||
| Cabazitaxel N-3 | 859498-31-0 | C57H61Cl6NO19 | ||
| Bis(4-isopropylphenyl)iodonium chloride | 97671-66-4 | C18H22ClI | ||
| (9H-fluoren-9-yl)methyl N-(carbamoylmethyl)carbamate | 115057-37-9 | C17H16N2O3 | ||
| NA | ||||
| 3’-deoxyinosine | ||||
| t-boc-N-amido-PEG2-bromide | 164332-88-1 | C9H18BrNO3 | ||
| (R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride | 1701403-10-2 | C22H24Cl2N6O | ||
| Coumarin 102 | 41267-76-9 | C16H17NO2 | ||
| Sodium 1-(2-hydroxyethyl)-1H-tetrazol-5-ylthiolate | 400827-72-7 | C3H5N4NaOS | ||
| (4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | 1187595-90-9 | C22H27N7O4S | ||
| (6R,7S)-Cefuroxime | C16H16N4O8S | |||
| (6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid | 927820-48-2 | C17H14N2O3 | ||
| 5-GERANOXY-7-METHOXYCOUMARIN | 7380-39-4 | C20H24O4 | ||
| ACETIC ACID 2-PHENOXYETHYL ESTER | 6192-44-5 | C10H12O3 | ||
| Danshen injection intermediate | ||||
| Azacitidine Isomer | ||||
| 6-FLUORO-4-HYDROXYCOUMARIN | 1994-13-4 | C9H5FO3 | ||
| Cefazolin Related Compound D | ||||
| Sugammadex sodium hexabromide intermediate | ||||
| (3S,5R,2R,3S)-posaconazole | ||||
| Acetoxy Ceftazidime Intermediate | ||||
| Flomoxef Intermediate FXMT | ||||
| 4-METHYL 6-HYDROXY 7-ACETOXY COUMARIN | 46895-13-0 | C12H10O6 | ||
| Pyrazole | 288-13-1 | C3H4N2 | ||
| 2,3,5,6-1H,4H-TETRAHYDROQUINOLIZINO[9,9A,1-GH]COUMARIN | 58336-35-9 | C15H15NO2 | ||
| 3-Fluorobenzylamine | 100-82-3 | C7H8FN | ||
| (3R,4R,5R)-Oseltamivir | ||||
| 4-Piperidinecarboxylic acid, 3-methyl-4-phenyl-, phenylmethyl ester, (3S,4R)- | 2357209-42-6 | C20H23NO2 | ||
| (9H-fluoren-9-yl)methyl (R)-(3-(2-bromophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate | ||||
| 2',3'-Didehydro-2',3'-dideoxy-5'-acetate inosine | 130676-57-2 | C12H12N4O4 | ||
| (R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone | 101328-85-2 | C11H13N3O | ||
| disodium tetrabromophthalate | 25357-79-3 | C8Br4Na2O4 | ||
| cytidylyl(5'->3')adenosine | 4833-63-0 | C19H25N8O11P | ||
| (S)-2-Amino-5-methoxytetralin Hydrochloride | 58349-17-0 | C11H15NO.HCl | ||
| Ceftazidime Mother Nucleus Double-Bond Shift | ||||
| 1,5-Pentanediaminium, N1,N1,N1,N5,N5,N5-hexaethyl-, hydroxide (1:2) | 109591-12-0 | C17H41N2O+ | ||
| L-Cephalexin | 34632-04-7 | C16H17N3O4S | ||
| Rimonabant hydrochloride | 158681-13-1 | C22H21Cl3N4O.ClH | ||
| 5-bromo-2-chloro-4’-ethoxydiphenylmethane | 461432-23-5 | C15H14BrClO | ||
| 3-isobutylglutaric anhydride | 185815-59-2 | C9H14O3 | ||
| 7-AMINO-3-(2-FUROYLTHIOMETHYL)-3-CEPHEM-4-CARBOXYLIC ACID | 80370-59-8 | C13H12N2O5S2 | ||
| 4-Bromopyrazole | 2075-45-8 | C3H3BrN2 | ||
| Fendizoic acid | 84627-04-3 | C20H14O4 | ||
| Lysergamide, 1-acetyl-N,N-diethyl- (6CI,7CI) | 500423 | C22H27N3O2 | ||
| 4-(4-Chloro-phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester | 5948-71-0 | C14H15ClN2O3 | ||
| (6β)-3-(1-Methyl-1H-tetrazole-5-ylthiomethyl)-7α-amino-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid benzhydryl ester | 66510-99-4 | C24H24N6O5S | ||
| tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | 571188-59-5 | C14H22N4O2 | ||
| N2-Isobutyryl-2'-Fluoro-2'-deoxyguanosine | 80681-25-0 | C14H18FN5O5 | ||
| 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]- | 477600-73-0 | C20H25N5 | ||
| 3-(1,1-diMethylethyl)-7a-ethenyltetrahydro-1-hydroxy-(3R,7aR)-3H,5H-Pyrrolo[1,2-c]oxazol-5-one | 1214741-21-5 | C12H19NO3 | ||
| (S)-1-(2-(1-aMino-2-Methylpropan-2-ylaMino)acetyl)pyrrolidine-2-carbonitrile dihydrochloride (AMino pyrrolidine) | 739364-93-3 | C11H22Cl2N4O | ||
| (Ac)Phe-Lys(Alloc)-PABC-PNP | C??H??N?O?? | |||
| 4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one | 170985-61-2 | C37H42F2N8O4 | ||
| Velpatasvir intermediate | 1378391-45-7 | C44H53N7O7 | ||
| 2',3',5'-TRI-O-BENZOYLINOSINE | 6741-88-4 | C31H24N4O8 | ||
| 5-AMINO-2'-DEOXYURIDINE FREE BASE | 5536-30-1 | C9H13N3O5 | ||
| 2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)- | 852148-49-3 | C21H22FNO4 | ||
| QUINUCLIDINE | 100-76-5 | C7H13N | ||
| 6-nitrocoumarin | 2725-81-7 | C9H5NO4 | ||
| (S)-1-Amino-3-chloro-2-propanol hydrochloride | 34839-13-9 | C3H9Cl2NO | ||
| 3,4-Dichloro-6-(trifluoromethyl)toluene | 74483-51-5 | C8H5Cl2F3 | ||
| BENZYL [2-AMINO-2-(HYDROXYIMINO)-1,1-DIMETHYLETHYL]CARBAMATE | 518047-98-8 | C12H17N3O3 | ||
| 4,7-Bis(2-bromo-5-thienyl)-2,1,3-benzothiadiazole | 288071-87-4 | C14H6Br2N2S3 | ||
| Platinum, dichloro(1,2-cyclohexanediamine-N,N')-, [sp-4-2-(1R-trans)]- | 61848-66-6 | C6H12Cl2N2Pt | ||
| 2,3,4,5-Tetrahydro-N,N-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-1-benzazepin-5-amine | 181210-18-4 | C19H24N2O2S | ||
| 6-(Phthalimidomethyl)morphanthridine | 74860-00-7 | C23H16N2O2 | ||
| (2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate | 900186-73-4 | C26H26N2O5 | ||
| Coumarin | 10172-75-5 | C26H18O7 | ||
| tert-butyl (5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oate | 474645-25-5 | C40H59N3O7 | ||
| 2'-CHLORO-2'-DEOXYURIDINE | 1042130 | C9H11ClN2O5 | ||
| FMOC-21-AMINO-4,7,10,13,16,19-HEXAOXAHENEICOSANOIC ACID | 882847-34-9 | C30H41NO10 | ||
| Posaconazole Impurity 16 | 213381-02-3 | C37H42F2N8O4 | ||
| 4,7-DIMETHYLCOUMARIN | 14002-90-5 | C11H10O2 | ||
| 5-Fluoroindole | 399-52-0 | C8H6FN | ||
| N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide | 182182-31-6 | C13H15FN2O2 | ||
| 5-BRDU 5-bromo-2'-deoxyuridine | ||||
| Material intermediate | 75286-83-8 | C52H38N4O8 | ||
| 4-methyl-7-nitro- 2H-chromen-2-one | 179897-88-2 | C10H7NO4 | ||
| Cefradine double nucleus | ||||
| 5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole | 97963-62-7 | C8H6F2N2OS | ||
| ADENYLYL(3'>5')CYTIDINE FREE ACID | 2382-66-3 | C19H25N8O11P | ||
| CEFMETAZOLE MMT ISOMER | ||||
| Cyclobutanecarboxylic acid, 3-(methylamino)-, 1-methylethyl ester, cis- | 2136718-64-2 | C9H17NO2 | ||
| (1S,2R,3S,5R)-2-(Benzyloxymethyl)-6-oxabicyclo[3.1.0]hexan-3-ol | 117641-39-1 | C13H16O3 | ||
| 3,4-Diiodopyrazole | 6645-70-1 | C3H2I2N2 | ||
| Cefcanel | 41952-52-7 | C19H18N4O5S3 | ||
| Indoline | 496-15-1 | C8H9N | ||
| 3-CYANOCOUMARIN | 15119-34-3 | C10H5NO2 | ||
| ((1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-(trimethylsilyloxy)hept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) | 2186604-89-5 | C42H80O3Si3 | ||
| Ceftazidime and Avibactam Sodium for Injection | ||||
| Methyl (R)-4,4-difluoropyrrolidine-2-carboxylate hydrochloride | 1408057-39-5 | C6H10ClF2NO2 | ||
| 7-DEAZA-2'-DEOXYINOSINE | 97224-58-3 | C11H13N3O4 | ||
| ETHYL 3-BUTENOATE | 1617-18-1 | C6H10O2 | ||
| N-ForMyl- | 104872-27-7 | C29H53NO5 | ||
| 3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine | 1022150-12-4 | C22H22N6O | ||
| 4,7-DIHYDROXYCOUMARIN | 1983-81-9 | C9H6O4 | ||
| (9H-fluoren-9-yl)methyl (S)-(1-(methylamino)-1-oxo-5-ureidopentan-2-yl)carbamate | ||||
| (9H-fluoren-9-yl)methyl (S)-(4-methyl-1-(methylamino)-1-oxopentan-2-yl)carbamate | ||||
| (1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline | 118864-75-8 | C15H15N | ||
| (2S,3R)-2-amino-3-methylpent-4-enamide | 2209873-96-9 | C6H12N2O | ||
| Carbamazepine intermediate | ||||
| N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride | 1260590-51-9 | C13H20ClN5 | ||
| tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl]carbaMate | 1172623-99-2 | C16H21F2NO4 | ||
| N,N-Diphenyl-1H-imidazole-1-carboxamide | 2875-79-8 | C16H13N3O | ||
| Coumarin | 10172-76-6 | C27H21NO6 | ||
| Pemetrexed intermediate | ||||
| (2S,5S)-ethyl 5-methylpyrrolidine-2-carboxylate 2,2,2- trifluoro acetate salt | 676560-85-3 | C10H16F3NO4 | ||
| ,100kg | 180048-73-1 | C11H14O4S | ||
| 1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride | 156077-56-4 | C12H29ClN4O3 | ||
| tert-butyl 4-(4-bromothiazol-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate | 1332301-87-7 | C13H17BrN2O2S | ||
| Cefmetazole Impurity 4 | 68576-47-6 | C15H17N7O4S4 | ||
| Otilonium Bromide intermediates | 51444-79-2 | C22H27NO4 | ||
| (5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone | 1027552-46-0 | C21H22FNO3 | ||
| 4F-MPH | 1354631-33-6 | C14H18FNO2 | ||
| 2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline dihydrochloride hydrate | 1802250-63-0 | C15H28Cl2N2O2 | ||
| Oseltamivir-13CD3 | 1093851-61-6 | C16H28N2O4 | ||
| tert-butyl (3R,4S,5S)-4-((S)-2-amino-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoate | 177423-00-6 | C19H38N2O4 | ||
| tert-butyl 6-bromo-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-1-carboxylate | 1403901-49-4 | C14H19BrN2O2 | ||
| McMMAE | 863971-24-8 | C49H78N6O10 | ||
| 2-Amino-4-bromo-3-fluorobenzoic acid | 1416013-62-1 | C7H5BrFNO2 | ||
| 4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one | 1246391-73-0 | C37H42F2N8O4 | ||
| Neratinib Maleate | 915942-22-2 | C34H33ClN6O7 | ||
| Oclacitinib Maleate(PF-03394197) | 1208319-27-0 | C19H27N5O6S | ||
| 4,6,7-trihydroxycoumarin | 22649-24-7 | C9H6O5 | ||
| Velpatasvir intermediate | 1378391-42-4 | C31H34BrNO8 | ||
| (2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester | 1420478-88-1 | C18H18BrN5O2 | ||
| (9H-fluoren-9-yl)methyl (4-(dimethoxymethyl)phenyl)carbamate | 475160-88-4 | C24H23NO4 | ||
| Posaconazole Impurity 18 | 213381-06-7 | C37H42F2N8O4 | ||
| 2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile | 1187594-13-3 | C22H31N7O3SSi | ||
| Δ3-Flomoxef sodium | ||||
| Derivatives intermediate 3 | 1213710-50-9 | |||
| Lixivaptan intermediate-V | 168079-19-4 | C19H16ClN3O | ||
| (+)-beta-Pinene oxide | 6931-54-0 | C10H16O | ||
| Ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate | 64485-82-1 | C7H9N3O3S | ||
| 1H-Tetrazole-1-acetic acid | 21732-17-2 | C3H4N4O2 | ||
| 4-Methylimidazole | 822-36-6 | C4H6N2 | ||
| (6R,7S)-Ceftriaxone Epimer | ||||
| [2S-[2α(R*),3β]]-N-ForMyl- | 104872-28-8 | C29H53NO5 | ||
| 7-DesMethylagoMelatine | 152302-45-9 | C14H15NO2 | ||
| 2-Propenoic acid, 3-(5-nitro-1-cyclohexen-1-yl)-, (2E)- | 899809-64-4 | C9H11NO4 | ||
| Aegelin | 456-12-2 | C18H19NO3 | ||
| 3,4-Diethyl 2-aMinothiophene-3,4-dicarboxylate | 104680-25-3 | C10H13NO4S | ||
| 2H-1-Benzopyran-2-one, 6-chloro-4-methyl- | 24145-78-6 | C10H7ClO2 | ||
| 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylbenzoic acid | 864725-62-2 | C18H12Cl2F3NO3 | ||
| -- | 93360-08-8 | C30H27N2O6P | ||
| Tadanafil intermediate (chloroacetyl porphyrin) | 171596-59-1 | C31H57BN4O6Si | ||
| 6-BROMO-4-HYDROXYCOUMARIN | 4139-61-1 | C9H5BrO3 | ||
| ETHYL 5-ISOPROPYL-3-METHYLISOXAZOLE-4-CARBOXYLATE | 357326-79-5 | C10H15NO3 | ||
| 4S-fluoropyrrolidine-2R-carboxylic acid methyl ester hydrochloride salt | 131176-03-9 | C6H11ClFNO2 | ||
| LOXO-292 | 2222755-14-6 | C29H31N9O3 | ||
| 1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)- | 1403902-78-2 | C16H31N3O3 | ||
| 7 8-DIHYDROXY-4-PHENYLCOUMARIN | 842-01-3 | C15H10O4 | ||
| 1,4-dihydroxy-2naphthoic acid methyl ester | 77060-74-3 | C12H10O4 | ||
| 2’,3’-dideoxy-2’,3’-didehydroinosine | ||||
| Fmoc-Ala-Ala-Asn-PABC-PNP | 1834516-06-1 | C39H38N6O11 | ||
| 2’-deoxyinosine | ||||
| Anti-Ceftriaxong | ||||
| benzyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate | ||||
| tert-butyl (S)-2-((trifluoromethoxy)methyl)piperazine-1-carboxylate | ||||
| tert-butyl (S)-2-(2,2,2-trifluoroethyl)piperazine-1-carboxylate | 1240582-25-5 | C11H19F3N2O2 | ||
| 4-hydroxy-6H-coumarin | 213481-01-7 | C15H15NO3 | ||
| 1-Azetidinecarboxylic acid, 3-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester | 951259-19-1 | C11H16IN3O2 | ||
| Cefuroxime Impurity 1（Cefuroxime Mother Nucleus） | ||||
| 2-(4-METHOXY-BENZYL)-2H-PYRAZOL-3-YLAMINE | 3528-45-8 | C11H13N3O | ||
| Ozagrel sodium | 130952-46-4 | C13H11N2NaO2 | ||
| 5-Mercapto-1H-tetrazole-1-methane sulphonic acid | 67146-22-9 | C2H4N4O3S2 | ||
| tert-butyl (R)-1-amino-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate | ||||
| (3S,4S,5S)-Oseltamivir | ||||
| Edoxaban Impurity 19 (1S,2R,4S) Mesylate | 1807315-98-5 | C17H26ClN5O6S | ||
| (9H-fluoren-9-yl)methyl (R)-(4-cyclohexyl-1-(methylamino)-1-oxobutan-2-yl)carbamate | ||||
| 1-Pyrrolidinecarboxylic acid, 3-(4-bromo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester, (3R)- | 2198312-46-6 | C12H18BrN3O2 | ||
| 3-(3'-TRIFLUOROMETHYL PHENYL) PROPANOL | 78573-45-2 | C10H11F3O | ||
| 3-acetyl-4-hydroxy-2-benzopyrone | 2555-37-5 | C11H8O4 | ||
| Cyclopenta[d]-1,2,3-oxathiazole-3(3aH)-carboxylic acid, tetrahydro-, 1,1-dimethylethyl ester, 2,2-dioxide, (3aS,6aR)- | 2145122-45-6 | C10H17NO5S | ||
| (R)-ethyl thiazolidine-4-carboxylate | C6H11NO2S | |||
| 5-BENZYLIDENEHYDANTOIN | 684838 | C10H8N2O2 | ||
| 5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester | 147125-14-2 | C33H56O3Si | ||
| Clopidogrel camphorsulfonate | 120202-68-8 | C26H32ClNO6S2 | ||
| (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity) | 130793-28-1 | C29H55NO6 | ||
| N4-Acetyl-2'-O-Methyl-cytidine | 113886-71-8 | C12H17N3O6 | ||
| 4,4'-Dibromo-2,2'-diiodobiphenyl | 852138-89-7 | C12H6Br2I2 | ||
| Sterolazole intermediate | ||||
| 2',3'-Anhydroinosine | 31766-13-9 | C10H10N4O4 | ||
| Δ3-Ceftiofur | ||||
| DeoxyBenzoinOxime | 952-06-7 | C14H13NO | ||
| (2S,5R)-6-(tert-butyldimethylsilyloxy)-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxamide | 2209874-02-0 | C14H25N3O3Si | ||
| 1,6-Diazabicyclo[3.2.1]oct-3-ene-2-carboxamide, 6-hydroxy-3-methyl-7-oxo-, (1R,2S,5R)- | 2209874-17-7 | C8H11N3O3 | ||
| S)-3-Cyano-5-methyl hexanoic acid ethyl ester | 181289-39-4 | C10H17NO2 | ||
| Trityl candesartan cilexetil | 170791-09-0 | C52H48N6O6 | ||
| 5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide | 89729-09-9 | C5H8O3S | ||
| 8-Benzyloxy-2'-deoxy-D-guanosine | 96964-90-8 | C17 H19 N5 O5 | ||
| 3-FLUOROINDOLE | 66946-81-4 | C8H6FN | ||
| Cefetecol | 117211-03-7 | C20H17N5O9S2 | ||
| methyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)pyrimidine-5-carboxylate | 1057682-17-3 | C15H22N4O4 | ||
| tert-butyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate | ||||
| △3-Cefuroxime | ||||
| Flomoxef Intermediate KDFA | ||||
| Polymethylhydrosiloxane | 9004-73-3 | C5H11OSi* | ||
| tert-butyl 4-(3-(methoxycarbonyl)phenyl)piperidine-1-carboxylate | 1016980-41-8 | C18H25NO4 | ||
| [3,3']Biazetidinyl-1-carboxylicacidtert-butylester | 1251018-87-7 | C11H20N2O2 | ||
| (1S,3R,4S)-Ethyl 4-AMino-3-((tert-butoxycarbonyl)aMino)cyclohexanecarboxylate Oxalate | 1093351-24-6 | C16H28N2O8 | ||
| Vorapaxar | 900161-12-8 | C29H34N2O5 | ||
| tert-butyl 4,4-Dimethyl-2,2-dioxooxathiazolidine-3-carboxylate | 454248-55-6 | C9H17NO5S | ||
| 1-BOC-4-(4-FLUORO-PHENYLAMINO)-PIPERIDINE | 288573-56-8 | C16H23FN2O2 | ||
| (r)-tert-butyl 5-methyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide | 863453-61-6 | C8H15NO5S | ||
| tert-butyl (2S)-2-(hydroxymethyl)-2-methylpyrrolidine-1-carboxylate | 1339022-10-4 | C11H21NO3 | ||
| 1-Pyrrolidinepropanol, β-amino-α-(2,3-dihydro-1,4-benzodioxin-6-yl)-, (αR,βR)- | 491833-28-4 | C15H22N2O3 | ||
| 4-(Bromomethyl)-7-(diethylamino)coumarin | 1256259-14-9 | C14 H16 Br N O2 | ||
| TERT-BUTYL 3-((2-ETHOXY-2-OXOETHYL)SULFONYL)AZETIDINE-1-CARBOXYLATE | 1648864-57-6 | C12H21NO6S | ||
| (1S,2R)-METHYL 2-(2-HYDROXYETHYL)CYCLOPROPANECARBOXYLATE | 2165933-01-5 | C7H12O3 | ||
| methyl 3-{[(tert-butoxy)carbonyl]amino}-5-iodothiophene-2-carboxylate | 1007171-35-8 | C11H14INO4S | ||
| ethyl 7-[6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]-1-cyclopropyl-8-methyl-4-oxo-quinoline-3-carboxylate | 446299-90-7 | C30H29N3O4 | ||
| 6,7-dichloro-4-methyl- 2H-chromen-2-one | 923019-32-3 | C10H6Cl2O2 | ||
| 3-(2-ETHOXYCARBONYL-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER | 877173-80-3 | C15H25NO5 | ||
| (3R,5S,2S,3S)-posaconazole | ||||
| tert-butyl (S)-1-amino-4-fluoro-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate | ||||
| (3R,4S,5R)-Oseltamivir | ||||
| (9H-fluoren-9-yl)methyl (R)-(3-(4-chlorophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate | ||||
| tert-butyl 4-bromo-3-(bromomethyl)thiophene-2-carboxylate | ||||
| Zanamivir | 139110-70-6 | C18H26N2O10 | ||
| 1-Piperazinecarboxylic acid, 4-(1,3-dihydro-1-oxo-5-isobenzofuranyl)-, 1,1-dimethylethyl ester | 1962174-33-9 | C17H22N2O4 | ||
| benzyl (2R,5R)-5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate | ||||
| 5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole | 368890-20-4 | C15H12ClF2N3O2S | ||
| Morpholin-2-yl-methylamine | 116143-27-2 | C5H12N2O | ||
| (1s-trans)-2-[(phenylmethoxy)methyl]-3-cyclopenten-1-ol | 188399-48-6 | C13H16O2 | ||
| 7-Fluoroindole | 387-44-0 | C8H6FN | ||
| N-Benzoyl-5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]adenosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | 104992-55-4 | C53H66N7O8PSi | ||
| (2S,4R)-4-BOC-AMINO PYRROLIDINE-2-CARBOXYLIC ACID METHYLESTER-HCL | 913742-54-8 | C11H21ClN2O4 | ||
| (S)-(2-Aminomethyl)-1-N-Boc-pyrrolidine HCl | 1190890-11-9 | C10H21ClN2O2 | ||
| 3',5'-di-o-acetyl-2-deoxy-5-azacytosine | 22432-93-5 | C12H16N4O6 | ||
| (2S,4S)-1-(tert-Butoxycarbonyl)-4-fluoro-2-hydroxymethylpyrrolidine | 317356-27-7 | C10H18FNO3 | ||
| (S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoic acid methyl ester hydrochloride | 170098-28-9 | C24H31NO3.HCl | ||
| 4a,5,9,10,11,12-hexahydro-1-bromo-3-methoxy-11-formyl-6H-benzofuro[3a,3,2-ef ][2]benzazepin-6-one | 122584-14-9 | C17H16BrNO4 | ||
| TF-BF | 209861-00-7 | C24H22F2O5 | ||
| Cefaclor, Delta-3 IsoMer | ||||
| Indacaterol interMediate | 435273-75-9 | C31H34N2O3 | ||
| 6-(4-Chlorophenyl)-2,3-Dihydro-2,2-DiMethyl-7-Phenyl-1H-Pyrrolizine | 133111-56-5 | C21H20ClN | ||
| 3-Iodo-1H-pyrazole-4-carbonitrile | 827316-44-9 | C4H2IN3 | ||
| CarbaMic acid, [(1S)-3-Methyl-1-(2-Methylpropyl)-2-oxo-3-butenyl]-, 1,1-diMethylethyl ester (9CI) | 247068-81-1 | C14H25NO3 | ||
| interMediates of eletriptan hydrobroMide | 180637-88-1 | C24H26N2O3S | ||
| Hydantoin | 461-72-3 | C3H4N2O2 | ||
| 4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one | 2243785-98-8 | C37H42F2N8O4 | ||
| 3-cinnamoyl-4-hydroxy-2H -chromen-2-one | 209973-90-0 | C18H12O4 | ||
| Sugammadex sodium 7-Bromide intermediates | ||||
| Oseltamivir Glucose Adduct 1 | ||||
| (3R,5R,2R,3S)-posaconazole | ||||
| 7-HYDROXY-4-PHENYLCOUMARIN 97 | 2555-30-8 | C15H10O3 | ||
| ditert-butyl pyrrolidine-1,2-dicarboxylate | 347189-18-8 | C14H25NO4 | ||
| NA | ||||
| Dextran Standard D0 | ||||
| Cefotifuromercapto | ||||
| tert-butyl 2-(5-bromo-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro[3.5]nonane-7-carboxylate | ||||
| BENZOIC ACID, 2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-3-NITRO-METHYL ESTER | 57113-90-3 | C13H16N2O6 | ||
| tert-butyl (R)-4-(((tert-butyldimethylsilyl)oxy)methyl)-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide | ||||
| (S)-3-PHENYL-BETA-ALANINOL HCL | 936499-93-3 | C9H14ClNO | ||
| Entecavir hydrate | ||||
| 3-Piperidinecarboxylicacid,2-methyl-,methylester(9CI) | 183786-23-4 | C8H15NO2 | ||
| 4-amino-2-deoxy-2,3-didehydro-N-acetylneuraminic acid | 130525-62-1 | C11H18N2O7 | ||
| 4-(4-HYDROXYPHENYL)BUTANOIC ACID | 1870718 | C10H12O3 | ||
| 4-Fluoro-1H-pyrazole | 35277-02-2 | C3H3FN2 | ||
| METHYL 1H-PYRAZOLE-4-CARBOXYLATE | 51105-90-9 | C5H6N2O2 | ||
| 2-(2-HYDROXYPHENYL)-4H-1,3-BENZOXAZIN-4-ONE | 1218-69-5 | C14H9NO3 | ||
| 3-Methylpyrazole | 1453-58-3 | C4H6N2 | ||
| 2-Cyanobenzyl bromide | 22115-41-9 | C8H6BrN | ||
| (2S,4S)-4-BOC-AMINO PYRROLIDINE-2-CARBOXYLIC ACID METHYLESTER-HCL | 168263-82-9 | C11H20N2O4 | ||
| 1,4-pentadiyn-3-ol | 56598-53-9 | C5H4O | ||
| Nilotinib Hydrochloride Monohydrate | 923288-90-8 | C28H25ClF3N7O2 | ||
| 4-Morpholinyl(4,5,6,7-tetrahydro-1H-pyrazolo-[4,3-c]pyridin-3-yl)methanone hydrochloride | 1220027-05-3 | C11H17ClN4O2 | ||
| 2-(Diethylamino)-N'-hydroxybenzenecarboximidamide | 1021244-00-7 | C11H17N3O | ||
| 7-(Diethylamino)-4-(hydroxymethyl)-2H-chromen-2-one | 54711-38-5 | C14H17NO3 | ||
| N-Deformyl-N-pivaloyl Orlistat | 1356017-35-0 | C33H61NO5 | ||
| 2'-O-(2-Methoxyethyl)cytidine | 223777-16-0 | C12H19N3O6 | ||
| tert-butyl 8-oxo-2,7-diazaspiro[4.4]nonane-2-carboxylate | 1251009-03-6 | C12H20N2O3 | ||
| 5-(1H-Pyrrol-1-yl)-2-mercaptobenzimidazole | 172152-53-3 | C11H9N3S | ||
| 1-Piperazinecarboxylic acid, 3,5-diMethyl-, 1,1-diMethylethyl ester, (3S,5S)- | 888327-50-2 | C11H22N2O2 | ||
| Methanesulfonic anhydride | 370071-69-5 | C8H6Br4O2 | ||
| Olmesartan intermediate | ||||
| (1R,3R)-Methyl-1,2,3,4-tetrahydro-2-chloroacetyl-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate | C22H18ClN2O5- | |||
| L-Inosine | 21138-24-9 | C10H12N4O5 | ||
| 1H-Pyrrolizine-7a(5H)-carboxylicacid,tetrahydro-,methylester(9CI) | 117375-15-2 | C9H15NO2 | ||
| 5-iodo-1-(2-fluoro-2-deoxyribofuranosyl)uracil | 55612-21-0 | C9H10FIN2O5 | ||
| 3-AMINO-8-BENZYL-8-AZABICYCLO[3.2.1]OCTANE (3-EXO)- | 76272-36-1 | C14H20N2 | ||
| tert-butyl (S)-(1,3-dihydrospiro[indene-2,4'-piperidin]-1-yl)carbamate | 2377357-06-5 | C18H26N2O2 | ||
| 4-Oxazolecarboxylic acid, 5-amino-, methyl ester | 63820-04-2 | C5H6N2O3 | ||
| (9H-fluoren-9-yl)methyl (R)-(1-(methylamino)-1-oxo-3-(pyridin-4-yl)propan-2-yl)carbamate | ||||
| (9H-fluoren-9-yl)methyl (S)-(1-cyclohexyl-2-(methylamino)-2-oxoethyl)carbamate | ||||
| NA | ||||
| Pluronic PE 4300 | ||||
| (7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol | 153004-31-0 | C32H47F5O2S | ||
| TFA-ap-dC | 115899-38-2 | C14H15F3N4O5 | ||
| (alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride | 521284-22-0 | C16H21ClN2O | ||
| (R)-tert-butyl 4-(4-(6-aMino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate | 877399-51-4 | C26H30Cl2FN5O3 | ||
| Posaconazole EnantioMer | ||||
| (αR,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1,2,4-triazole-1-butanoic Acid | 483340-19-8 | C13H13F2N3O3 | ||
| 6-[[[4-[(1-Oxo-2-propen-1-yl)oxy]butoxy]carbonyl]oxy]-2-naphthalenecarboxylic acid 2,2'-[2-(methoxycarbonyl)-1,4-phenylene] ester | 914918-26-6 | C46H40O16 | ||
| Methyl 1-(MethylaMino)cyclobutanecarboxylate hydrochloride | 1247180-93-3 | C7H13NO2 | ||
| 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester | 112811-71-9 | C16H15F2NO4 | ||
| tert-butyl 3-oxohexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxylate | 1246551-25-6 | C11H19N3O3 | ||
| Velpatasvir intermediate | 1378391-43-5 | C44H55N3O13 | ||
| tert-butyl 4-(chloromethyl)-4-(hydroxymethyl)piperidine-1-carboxylate | 1312131-45-5 | C12H22ClNO3 | ||
| METHYL 2-METHYL-4-HYDROXY-2H-THIENO[2,3-E]-1,2-THIAZINE-3-CARBOXYLATE-1,1-DIOXIDE | 59804-25-0 | C9H9NO5S2 | ||
| TERT-BUTYL 2,8-DIAZASPIRO[4.5]DECAN-2-CARBOXYLATE HYDROCHLORIDE | 869976-20-5 | C13H24N2O2.HCl | ||
| Ethyl 6,7-difluoro-2-ethylmercapto-4-hydroxyquinoline-3-carboxylate | 154330-67-3 | C14H13F2NO3S | ||
| ethyl 2-amino-4-(3-chlorophenyl)thiophene-3-carboxylate | 473438-03-8 | C13H12ClNO2S | ||
| 5-(2-chloroethyl)-2,3-dihydrobenzofuran | 943034-50-2 | C10H11ClO | ||
| 5-METHYLINDOLE-3-CARBOXYLIC ACID METHYL ESTER | 227960-12-5 | C11H11NO2 | ||
| cis-Pinane | 6876-13-7 | C10H18 | ||
| AURORA KA-1056 | 224313-74-0 | C10H8N2O4 | ||
| ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate | 161798-01-2 | C14H13NO4S | ||
| 5-Ethyl-2H-pyrazole-3-carboxylic acid ethyl ester | 26308-40-7 | C8H12N2O2 | ||
| (R)-1-Boc-3-hydroxypyrrolidine | 109431-87-0 | C9H17NO3 | ||
| Boceprevir InterMediates | 565456-77-1 | C9H15NO2.ClH | ||
| 3-(6-Chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol hydrochloride | 188416-20-8 | C16H13ClF3N5O.ClH | ||
| Benzoic acid, 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]-, methyl ester | 153559-48-9 | C25H30O2 | ||
| 3-Iodo-1H-pyrazole-4-carboxylic acid ethyl ester | 827316-43-8 | C6H7IN2O2 | ||
| (R)-(2-Aminomethyl)-1-N-Boc-pyrrolidine HCl | 1190890-12-0 | C10H21ClN2O2 | ||
| D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid | 79276-23-6 | C15H25N3O6 | ||
| (3R,3αS,6αR)-Hexahydrofuro[2,3-β]furan-3-yl-4-nitrophenyl carbonate | 252873-35-1 | C13H13NO7 | ||
| 3-Azabicyclo[3.1.0]hexane-1,3-dicarboxylic acid, 3-(1,1-dimethylethyl) 1-ethyl | 1204820-62-1 | C13H21NO4 | ||
| Cefovecin | 234096-34-5 | C17H19N5O6S2 | ||
| tert-butyl (3S,4R)-4-aMino-3-fluoropiperidine-1-carboxylate | 907544-20-1 | C10H19FN2O2 | ||
| (3R,5R)-1-Boc-3,5-diMethylpiperazine | 438049-91-3 | C11H22N2O2 | ||
| 7-hydroxy-4-Methyl-2-oxo-2H-1-Benzopyran-8-carboxaldehyde | 14003-96-4 | C11H8O4 | ||
| Cyclopropanecarboxylic acid, 1-aMino-, 1,1-diMethylethyl ester | 159871-51-9 | C8H15NO2 | ||
| (2S,5R)-ethyl 5-(benzyloxyaMino)piperidine-2-carboxylate | 1416134-47-8 | C15H22N2O3 | ||
| 1-[(2S)-2-(benzyloxy)propanoyl]pyrrolidine | 122151-32-0 | C14H19NO2 | ||
| 2-(methylamino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate | 1180002-01-0 | C15H23N3O4 | ||
| (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate | 179324-87-9 | C17H29BF3NO4 | ||
| TERT-BUTYL 3-BROMO-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE-7(8H)-CARBOXYLATE | 723286-80-4 | C10H15BrN4O2 | ||
| 1-Boc-2,5-Dihydro-1H-pyrrole-3-boronic acid, pinacol ester | 212127-83-8 | C15H26BNO4 | ||
| Posaconazole Diastereoisomer 12 | 213381-04-5 | C37H42F2N8O4 | ||
| tert-butyl(R)-3-((6-chloropyrazin-2-yl)oxy)piperidine-1-carboxylate | 1147998-31-9 | C14H20ClN3O3 | ||
| 3-Aminopyrazole | 1820-80-0 | C3H5N3 | ||
| Cefuroxime double mother nucleus | ||||
| Derivatives intermediate 2 | 1213710-57-6 | C26H38N2O3 | ||
| Lixivaptan intermediate-IV | 179063-21-9 | C19H14ClN3O3 | ||
| 5-Methoxy cytidine | 37805-90-6 | C10H15N3O6 | ||
| 1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 864686-28-2 | C28H33N3O2 | ||
| 6-bromo-7-hydroxy-4-(hydroxymethyl)-2H-chromen-2-one | 223420-41-5 | C10H7BrO4 | ||
| (1S,5R)-1-(3-fluorophenyl)-3-oxabicyclo[3.1.0]hexan-2-one | 528587-70-4 | C11H9FO2 | ||
| tert-butyl (E)-4-bromo-3-(4-ethoxy-4-oxobut-2-en-1-yl)thiophene-2-carboxylate | ||||
| tert-butyl (R)-4-((benzyloxy)methyl)-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide | ||||
| Levofloxacin R-Isomer HCl | ||||
| methyl (2R,7aR)-2-(benzyloxy)tetrahydro-1H-pyrrolizine-7a(5H)-carboxylate | ||||
| Cefetrizole | 65307-12-2 | C16H15N5O4S3 | ||
| 1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with 1,3-diisocyanatomethylbenzene | 2599683 | C15H20N2O5 | ||
| 2'-DEOXY-5-FLUOROCYTIDINE | 10356-76-0 | C9H12FN3O4 | ||
| ECHINOCANDIN B | 79411-15-7 | C34H51N7O15 | ||
| 1-[((7R)-7-AMINO-4-CARBOXY-3,4-DIDEHYDROCEPHAM-3-YL)METHYL]-1H-IMIDAZO[1,2-B]PYRIDAZIN-4-IUM IODIDE | 197897-11-3 | C14H16IN5O3S | ||
| Coumarin | 1555972 | C19H19NO2 | ||
| Nevirapine intermediate | ||||
| Fluvis group intermediate | ||||
| (1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate | 167271-60-5 | C15H14N4O3S | ||
| 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester hydrochlorid | 1422956-25-9 | C28H31ClN4O3 | ||
| 1,4-bis(4-chloro-2-fluoro-5-nitrophenyl)butane-1,4-dione | 1292836-19-1 | C16H8Cl2F2N2O6 | ||
| Isavuconazole | 338990-63-9 | C40H43ClF2N8O7S | ||
| Eribulin intermediateB | ||||
| (S)-5-fluoro-3-methylisobenzofuran-1(3H)-one | 1803573-19-4 | C9H7FO2 | ||
| 6-Chloro-2,3,4,5-tetrahydro-7,8-dimethoxy-1-(4-methoxyphenyl)-1H-3-benzazepine | 67287-53-0 | C19H22ClNO3 | ||
| Phosphonic acid, (3-methyloxiranyl)-, (2R-cis)-, compd. with (R)-alpha-methylbenzenemethanamine (1:1), monohydrate (9CI) | 65794-75-4 | C11H18NO4P | ||
| 4-methyl-8-nitro-2H- chromen-2-one | 184290-97-9 | C10H7NO4 | ||
| Oseltamivir Fructose Adduct 1 | ||||
| Cephalexin ethyl homologue | ||||
| tert-butyl (R)-2-(2,2,2-trifluoroethyl)piperazine-1-carboxylate | 1240586-07-5 | C11H19F3N2O2 | ||
| Canagliflozin Intermediate epimers | ||||
| (3R,4S,5S)-Oseltamivir | ||||
| 1(2H)-Pyridinecarboxylic acid, 2-(aminocarbonyl)-5-[[(1,1-dimethylethoxy)carbonyl]hydroxyamino]-5,6-dihydro-3-methyl-, 1,1-dimethylethyl ester, (2S,5R)- | 2209872-72-8 | C17H29N3O6 | ||
| INDEX NAME NOT YET ASSIGNED | 2070009-39-9 | C35H39N5O10 | ||
| (9H-fluoren-9-yl)methyl ((2S,3R)-3-hydroxy-1-(methylamino)-1-oxobutan-2-yl)carbamate | ||||
| 1,4-BIS-[4-(6-ACRYLOYLOXYHEXYLOXY)BENZOYLOXY]-2-METHYLBENZENE | 125248-71-7 | C39H44O10 | ||
| (S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one | 156732-13-7 | C32H32N2O | ||
| pinanyl hydroperoxide | 28324-52-9 | C10H18O2 | ||
| iodomethyl (2S-cis)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide | 76247-39-7 | C9H12INO5S | ||
| Intermediate 1 | 2203433-07-0 | |||
| 8-bromoxanthosine | 3001-46-5 | C10H11BrN4O6 | ||
| Amic acid | ||||
| ATORVASTATIN SODIUM | 134523-01-6 | C33H36FN2NaO5 | ||
| N(4)-methylcytidine | 10578-79-7 | C10H15N3O5 | ||
| qianhucoumarin A | 150135-35-6 | C19H20O6 | ||
| Ethyl N-Cbz-4-Oxopyrrolidine-3-carboxylate | 51814-19-8 | C15H17NO5 | ||
| lupinine hydrochloride | 1539014 | C10H20ClNO | ||
| METHYL ESTER, 4,5-BIS(2-METHOXYETHOXY)-2-NITROBENZOIC ACID | 501684-22-6 | C14H19NO8 | ||
| Decursinol | 23458-02-8 | C14H14O4 | ||
| Acetoxy Empagliflozin | 915095-99-7 | C31H35ClO11 | ||
| Side chain of Cefotetan | 955010-42-1 | C10H13NO5S2 | ||
| Methyl 2-(2,3-dichlorobenzylidine)acetoacetate | 74073-22-6 | C12H10Cl2O3 | ||
| Methyl2-Methyl-1H-indole-3-carboxylate | 65417-22-3 | C11H11NO2 | ||
| 5-BROMOCYTIDINE | 3066-86-2 | C9H12BrN3O5 | ||
| Oseltamivir Fructose Adduct 5 | ||||
| Oseltamivir Glucose Adduct 3 | ||||
| 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 2-bromo-4-(2-fluorophenyl)-9-methyl- | 57801-95-3 | C15H10BrFN4S | ||
| cefaloram | 859-07-4 | C18H18N2O6S | ||
| tert-butyl (R)-3-(4-bromo-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate | ||||
| β-AMino-α-hydroxycyclobutanebutanaMide Hydrochloride | 394735-23-0 | C8H17ClN2O2 | ||
| 2'-O-(2-Methoxyethyl)guanosine | 473278-54-5 | C13H19N5O6 | ||
| tert-butyl 7-oxo-2,6-diazaspiro[3.4]octane-2-carboxylate | 1234616-51-3 | C11H18N2O3 | ||
| (2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one | 112849-17-9 | C39H66O3Si2 | ||
| tert-butyl (3aS,6aR)-tetrahydrocyclopenta[d][1,2,3]oxathiazole-3(3aH)-carboxylate 2,2-dioxide | ||||
| (2S,5R)-N-(3-aminopropyloxy)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide trifluoroacetic acid salt | 1572989-40-2 | C12H19F3N4O9S | ||
| Triazinate | 41191-04-2 | C21H25ClN6O2.C2H6O3S | ||
| 5,pregnane-7 alpha,21-dicarboxylic acid,17-ydroxy-11-methylsulfonic acid-3-ketone,-butyrolectone,methyl ester cas:(intermediate of eplerenone) | 192704-58-8 | C25H34O8S | ||
| METHYL 2-FORMYL-4-METHYL-4H-FURO[3,2-B]PYRROLE-5-CARBOXYLATE | 164667-56-5 | C10H9NO4 | ||
| N-(3-BUTEN-1-YL)PHTHALIMIDE | 52898-32-5 | C12H11NO2 | ||
| 9ALPHA,11ALPHA-DIHYDROXY-15,15-DIFLUORO-16-PHENOXY-17,18,19,20-TETRANOR-PROSTA-5Z,13E-DIEN-1-OIC ACID | 209860-88-8 | C22H28F2O5 | ||
| 2-Phenyl-3H-azirine-3-carboxylic acid methyl ester | 18709-45-0 | C10H9NO2 | ||
| 2-(Aminoacetylamino)-3-(o-chlorobenzoyl)-5-ethylthiophene | 50509-09-6 | C15H15ClN2O2S | ||
| Methyl 5-fluoro-2-methyl-3-nitrobenzoate | 697739-03-0 | C9H8FNO4 | ||
| TERT-BUTYL 2,9-DIAZASPIRO[5.5]UNDECANE-2-CARBOXYLATE | 189333-03-7 | C14H26N2O2 | ||
| tert-butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate | 1181816-12-5 | C11H17NO3 | ||
| JYWBTFDJVRKRBZ-TXEJJXNPSA-N | 771469-22-8 | C14H20N2O2 | ||
| DL-NORADRENALINE | 138-65-8 | C8H11NO3 | ||
| JLEQLXGZAIAEFX-VRQJEYPFSA-N | 1795790-92-9 | C22H19N3O5 | ||
| AHLBNYSZXLDEJQ-FICKONGGSA-N | 1620409-08-6 | C29H53NO5 | ||
| ETHYL 2-OXAZOLECARBOXYLATE | 33036-67-8 | C6H7NO3 | ||
| 1-(3-METHOXY-PHENYL)-ETHYLAMINE | 62409-13-6 | C9H13NO | ||
| 4-Iodopyrazole | 3469-69-0 | C3H3IN2 | ||
| methyl (4-(5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-2-methylbenzoyl)glycinate | 864731-38-4 | C21H17Cl2F3N2O4 | ||
| 4-HYDROXY-7-METHYLCOUMARIN | 18692-77-8 | C10H8O3 | ||
| Tripropargyl benzene-1,3,5-tricarboxylate | 871830-29-4 | C18H12O6 | ||
| Larotaxel intermediate(A-3) | 156294-33-6 | C31H36O10 | ||
| 8-isopropyl-4-methyl- 2H-chromen-2-one | 923019-31-2 | C13H14O2 | ||
| (3R,5S,2R,3S)-posaconazole | ||||
| BENZYL 3-PYRROLINE-1-CARBOXYLATE | 31970-04-4 | C12H13NO2 | ||
| ethyl 2-(methylthio)indolizine-3-carboxylate | 123471-45-4 | C12H13NO2S | ||
| benzyl (S)-2-(2,2,2-trifluoroethyl)piperazine-1-carboxylate | ||||
| Flomoxef Intermediate OXA | ||||
| NA | ||||
| Selamectin | 220119-17-5 | C43H63NO11 | ||
| 4-Methoxy-3-(3-methoxypropoxy)benzenemethanol | 172900-74-2 | C12H18O4 | ||
| 8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-diMethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-Methoxy-3,6-dioxo-, Methyl ester, (1aR,5S,8S,10R,22aR)- | 1206524-84-6 | C30H40N4O7 | ||
| 2,2-DIMETHYLCYANOACETATE METHYL ESTER | 72291-30-6 | C6H9NO2 | ||
| 6,11-dihydro-11-oxo-dibenz[b,e]oxepin-2-acetate,methyl ester | 55689-64-0 | C17H14O4 | ||
| Vilanterol | 503068-34-6 | C24H33Cl2NO5 | ||
| 3'-AMINO-BIPHENYL-3-CARBOXYLIC ACID METHYL ESTER | 168619-25-8 | C14H13NO2 | ||
| Methyl-2,3-O-isopropylidene-D-ribofuranoside | 72402-14-3 | C9H16O5 | ||
| 8-BENZYL-3-EXO-(3-ISOPROPYL-5-METHYL-4H-1,2,4-TRIAZOL-4-YL)-8-AZABICYCLO[3.2.1]OCTANE | 423165-13-3 | C20H28N4 | ||
| {4-[(4-fluorobenzil)aMMino]-2-nitrofenil}carbaMMato di etile | 150812-23-0 | C16H16FN3O4 | ||
| N-{3-[5-(2-chloro-4-pyriMidinyl)-2-(1,1-diethylethyl)-1,3-thiazol-4-yl]-2-fluoraphenyl}-2,6-difluorobenzenesulfonaMide | 1195768-23-0 | C23H18ClF3N4O2S2 | ||
| (S)-5-methoxy-1,2,3,4-tetrahydro-N-(phenylmethyl)- 2-Naphthalenamine (Rotigotine) | 58349-23-8 | C18H21NO | ||
| 5-methoxy-1,2,3,4-tetrahydro-N-(phenylmethyl)- 2-Naphthalenamine (Rotigotine) | 136247-07-9 | C18H21NO | ||
| N-Methyl-N-(naphtha-1-yleMnthyl)-aMMoniuM-acetate | ||||
| N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide | 871700-25-3 | C26H23FIN5O4 | ||
| 5-Chloro-2-hydroxy-3-nitro-(1,1-biphenyl)-3-carboxylic acid | 376592-58-4 | C13H8ClNO5 | ||
| (4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione | 1206102-10-4 | C19H19BrN2O4 | ||
| Aliskiren inter-11 | 387353-77-7 | C9H15ClO2 | ||
| 1-benzyl-4-methylpiperidin-3-ol | 384338-20-9 | C13H19NO | ||
| 4-hydroxy-N,N-diphenyl-(4R)-2-Pentynamide | 899809-61-1 | C17H15NO2 | ||
| Vilanterol Trifenatate | 503070-58-4 | C44H49Cl2NO7 | ||
| 2,6-Dichloro-3,5-dimethoxyaniline | 872509-56-3 | C8H9Cl2NO2 | ||
| (S)-3,3-Dimethyl-2-((1R,2R)-2-pent-4-ynyl-cyclopropoxycarbonylamino)-butyric acid, tert-butylamine salt | 1425038-21-6 | C19H34N2O4 | ||
| methyl (33R,35S,91R,92R,5S,Z)-5-(tert-butyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphan-12-yne-35-carboxylate | 1425038-23-8 | C30H36N4O7 | ||
| 1-Aminoindan sulfate (Rasagiline) | 936474-09-8 | 2(C9H11N).H2SO4 | ||
| N-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)acetamide (Tamibarotene) | 139162-43-9 | C16H23NO | ||
| 6-aMino-3-cyclopropyl-1-(2-fluoro-4-iodophenyl)pyriMidine-2,4(1H,3H)-dione | 871700-28-6 | C13H11FIN3O2 | ||
| 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione | 871700-24-2 | C18H15FIN3O4 | ||
| 2-CHLORO-1,3-DIMETHYLAMINO TRIMETHINIUM HEXAFLUOROPHOSPHATE | 291756-76-8 | C7H14ClF6N2P | ||
| (4S)-(2,2-dimethyl-1,3-dioxolan-4-yl)-3-(4- hydroxybenzene) propanoic acid,methyl ester (Landiolol) | 144256-11-1 | C15H20O5 | ||
| 2,2-DIMETHYLTHIOPROPIONAMIDE | 630-22-8 | C5H11NS | ||
| Benzaldehyde, 4-methoxy-3-(3-methoxypropoxy)- | 172900-75-3 | C12H16O4 | ||
| Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate | 1206102-08-0 | C16H17NO6 | ||
| 2,7-DibroMo-9,9-difluoro-9H-fluorene | 1229603-71-7 | C13H6Br2F2 | ||
| 1-(2,2-diMethoxyethyl)-5-Methoxy-6-(Methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid | 1335210-23-5 | C13H17NO8 | ||
| (6S)-6-[5-[7-[2-(1R,3S,4S)-2-Azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane hydrochloride (1:4) | 1499193-67-7 | C35H32F2N6 | ||
| Ethanol, 2-[(2,6-dichlorophenyl)Methoxy]- | 85309-91-7 | C9H10Cl2O2 | ||
| 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(MethylaMino)pyriMidine-2,4(1H,3H)-dione | 871700-22-0 | C14H13FIN3O2 | ||
| Dabrafenib Mesylate(GSK-2118436B) | 1195768-06-9 | C24H24F3N5O5S3 | ||
| (R)-2-((S)-2,2-diMethyl-5-oxo-1,3-dioxolan-4-yl)-3-(naphthalen-2-yl)propanoic acid | 198568-07-9 | C18H18O5 | ||
| N-{3-[(2-chloro-4-pyriMidinyl)acetyl]-2-fluorophenyl}-2,6-difluorobenzenesulfonaMide | C18H11ClF3N3O3S | |||
| Phosphonic acid, [[5-(3-fluorophenyl)-2-pyridinyl]Methyl]-, diethyl ester | 380894-77-9 | C16H19FNO3P | ||
| 2,2'-dithiobis[N-methylbenzamide] | 2527-58-4 | C16H16N2O2S2 | ||
| (S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine) | 101403-24-1 | C14H21NO | ||
| 4-Morpholinecarboxamide, N-(2-aminoethyl)-, ethanedioate (Landiolol) | 947674-94-4 | C9H17N3O6 | ||
| 7-Amino-8-oxo-3-(cis-prop-1-enyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenylmethyl ester hydrochloride | 106447-41-0 | C23H22N2O3S | ||
| 2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one | 283173-80-8 | C11H8BrFN2O | ||
| 8-FLUORO-3-IODOQUINOLINE | 866782-59-4 | C9H5FIN | ||
| 2-(4-MESYLPHENYL)-1-(6-METHYLPYRIDIN-3-YL)- ETHAN-1-ONE | 221615-75-4 | C15H15NO3S | ||
| GSK1120212 (DMSO solvate) | 1187431-43-1 | C28H29FIN5O5S | ||
| (4R,12aS)-N-(2,4-difluorobenzyl)-7-benzylhydroxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxaMide | 1206102-11-5 | C27H25F2N3O5 | ||
| Methyl 3-{[(2,6-difluoropheyl)sulfonyl]aMino}-2-fluorabenzoate | 1195768-19-4 | C14H10F3NO4S | ||
| (4R,12aS)-7-(benzyloxy)-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione | 1206102-09-1 | C19H20N2O4 | ||
| DiMethyl 3-(benzyloxy)-1-(2,2-diMethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate | 1357289-08-7 | C20H23NO8 | ||
| (3R,3aS,4S,4aS,7R,9aR)-3-Methyl-7-nitro-1-oxo-N,N-diphenyl-1,3,3a,4,4a,5,6,7,8,9a-decahydronaphtho[2,3-c]furan-4-carboxamide | 900186-72-3 | C26H26N2O5 | ||
| (R)-4-Propyldihydrofuran-2(3H)-one | 63095-51-2 | C7H12O2 | ||
| (S)-4-Benzyl-3-((S)2-((R) -2-BroMo-2((2S,4S)-4-isopropyl-5- oxo-tetrahydro-furan-2-yl)-3-Methyl-butyryl)-oxaxolidin-2-one | 173154-00-2 | C24H32BrNO5 | ||
| 952680-40-9 | 952680-40-9 | |||
| 8-fluoro-3-(phenylsulfonyl)- Quinoline | 866782-60-7 | C15H10FNO2S | ||
| 2-Cyano-2,2-diMethyl-acetaMide | C5H8N2O | |||
| (E)-2-chloro-3-iMino-N,N-diMethylprop-1-en-1-aMine hydrochloride | 1352804-27-3 | C5H10Cl2N2 | ||
| 2-[4-Methoxy-3-(3-Methoxy-propoxy)-benzoyl]-3-Methyl-butyric acid Methyl ester | C18H26O6 | |||
| Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate | 1206102-07-9 | C17H19NO6 | ||
| (3-exo)-8-Methyl-8-azabicyclo[3.2.1]octane-3-thiol hydrochloride | 1141886-66-9 | C8H15NS.HCl | ||
| 2-{Hydroxy-[4-Methoxy-3-(3-Methoxy-propoxy)-phenyl]-Methyl}-3-Methyl-butyric acid Methyl ester | C18H28O6 | |||
| 2-Propenoic acid, 3-(5-nitro-1-cyclohexen-1-yl)-, (1R)-4-(diphenylaMino)-1-Methyl-4-oxo-2-butyn-1-yl ester, (2E)- | 899809-60-0 | C26H24N2O5 | ||
| PyridaziniuM, 1-aMino-, iodide (1:1) | 35073-04-2 | C4H6IN3 | ||
| 2-ethyl-4-(4-Methyl-1-piperazinyl)- 10H-Thieno[2,3-b][1,5]benzodiazepine | 61325-71-1 | C18H22N4S | ||
| 1-(3,4-DiMethoxy-phenyl)-3-Methyl-butan-1-one | 132858-47-0 | C13H18O3 | ||
| Ledipasvir Intermediate N-2 | ||||
| (1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid | 900161-13-9 | C17H25NO6 | ||
| Axitinib Impurity B | 944835-85-2 | C15H13N3OS | ||
Bulk Drug Intermediates
Auschemicals distinguishes itself by the very variety and quality of its products that includes pharmaceutical intermediates, API, chemical reagent, organic intermediates, antibiotic etc.
Bulk drug intermediates are the drugs used as raw elements for the making of bulk drugs, or they can refer to a material generated during synthesis of an API that must endure further molecular change or processing before it matures as an API.
The formation of bulk drug substances employ three major kinds of processes: fermentation, organic chemical synthesis, plus biological and natural extraction .
